Non-clinical pharmacokinetic behavior of ginsenosides

Park, 2017, Biotransformation of major ginsenosides in ginsenoside model culture by lactic acid bacteria, J Ginseng Res, 41, 36, 10.1016/j.jgr.2015.12.008

Cheng, 2005, Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action, Acta Pharmacol Sin, 26, 143, 10.1111/j.1745-7254.2005.00034.x

Zhu, 2012, Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia, Neuroscience, 202, 342, 10.1016/j.neuroscience.2011.11.070

Park, 2012, Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice, J Pharmacol Exp Ther, 341, 59, 10.1124/jpet.111.189035

Zhang, 2013, The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis, J Cardiovasc Pharm, 62, 50, 10.1097/FJC.0b013e31828f8d45

Shi, 2011, Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats, Pharm Biol, 49, 900, 10.3109/13880209.2011.554845

Zhu, 2009, Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis, J Cell Biochem, 108, 117, 10.1002/jcb.22233

Li, 2012, The effects of ginsenoside Rb1 on JNK in oxidative injury in cardiomyocytes, Arch Pharm Res, 35, 1259, 10.1007/s12272-012-0717-3

Wang, 2013, Protective effect of ginsenoside Rb1 against lung injury induced by intestinal ischemia-reperfusion in rats, Molecules, 18, 1214, 10.3390/molecules18011214

Wong, 2010, Asian ginseng extract inhibits in vitro and in vivo growth of mouse Lewis lung carcinoma via modulation of ERK-p53 and NF-κB signaling, J Cell Biochem, 111, 899, 10.1002/jcb.22778

Geng, 2016, Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice, Beijing Da Xue Xue Bao Yi Xue Ban, 48, 496

Baek, 2016, In vitro and in vivo anti-inflammatory activities of Korean Red Ginseng-derived components, J Ginseng Res, 40, 437, 10.1016/j.jgr.2016.08.003

Zhang, 2015, Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation, J Pharmacol Exp Ther, 352, 315, 10.1124/jpet.114.218750

Tan, 2014, Anti-inflammatory effect of ginsenoside Rb1 contributes to the recovery of gastrointestinal motility in the rat model of postoperative ileus, Biol Pharm Bull, 37, 1788, 10.1248/bpb.b14-00441

Hwang, 2015, An enzymatically fortified ginseng extract inhibits proliferation and induces apoptosis of KATO3 human gastric cancer cells via modulation of Bax, mTOR, PKB and IκBα, Mol Med Rep, 11, 670, 10.3892/mmr.2014.2704

Lee, 2014, Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80, J Ginseng Res, 38, 89, 10.1016/j.jgr.2013.10.001

Hou, 2014, Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats, BMC Complem Altern Med, 14

Tao, 2014, Ginsenoside Rg1 protects mouse liver against ischemia-reperfusion injury through anti-inflammatory and anti-apoptosis properties, J Surg Res, 191, 231, 10.1016/j.jss.2014.03.067

Gao, 2015, Anti-inflammatory function of ginsenoside Rg1 on alcoholic hepatitis through glucocorticoid receptor related nuclear factor-kappa B pathway, J Ethnopharmacol, 173, 231, 10.1016/j.jep.2015.07.020

Park, 2012, Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways, Food Chem Toxicol, 50, 2736, 10.1016/j.fct.2012.05.027

Ko, 2009, Autophagy inhibition enhances apoptosis induced by ginsenoside Rk1 in hepatocellular carcinoma cells, Biosci Biotech Biochem, 73, 2183, 10.1271/bbb.90250

Toh, 2011, Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells, Chin Med UK, 6, 4, 10.1186/1749-8546-6-4

Yokozawa, 1985, Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats, Chem Pharm Bull (Tokyo), 33, 869, 10.1248/cpb.33.869

Kim, 2010, Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells, Biol Pharm Bull, 33, 325, 10.1248/bpb.33.325

Seo, 2016, Black ginseng extract exerts anti-hyperglycemic effect via modulation of glucose metabolism in liver and muscle, J Ethnopharmacol, 190, 231, 10.1016/j.jep.2016.05.060

Wei, 2015, Ginsenoside compound K suppresses the hepatic gluconeogenesis via activating adenosine-5′ monophosphate kinase: a study in vitro and in vivo, Life Sci, 139, 8, 10.1016/j.lfs.2015.07.032

Yang, 2012, Therapeutic effect of ginsenoside Rd in rats with TNBS-induced recurrent ulcerative colitis, Arch Pharm Res, 35, 1231, 10.1007/s12272-012-0714-6

Li, 2011, Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53, Cancer Lett, 301, 185, 10.1016/j.canlet.2010.11.015

Wang, 2008, Potential role of ginseng in the treatment of colorectal cancer, Am J Chin Med, 36, 1019, 10.1142/S0192415X08006545

Lee, 2009, Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines, Biosci Biotechnol Biochem, 73, 811, 10.1271/bbb.80637

Kim, 2009, Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel, Arch Pharm Res, 32, 755, 10.1007/s12272-009-1515-4

Yokozawa, 1998, A study of ginsenoside-Rd in a renal ischemia-reperfusion model, Nephron, 78, 201, 10.1159/000044911

Baek, 2017, Protective effect of ginsenosides Rk3 and Rh4 on cisplatin-induced acute kidney injury in vitro and in vivo, J Ginseng Res, 41, 233, 10.1016/j.jgr.2016.03.008

Kang, 2013, Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism, J Ginseng Res, 37, 379, 10.5142/jgr.2013.37.379

Cui, 1996, Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng, Scand J Clin Lab Invest, 56, 151, 10.3109/00365519609088602

He, 2012, Biotransformation of ginsenosides and their aglycones, Int J Biomed Pharmaceut Sci, 6, 45

Qi, 2011, Metabolism of ginseng and its interactions with drugs, Curr Drug Metab, 12, 818, 10.2174/138920011797470128

Xu, 2003, Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats, J Ethnopharmacol, 84, 187, 10.1016/S0378-8741(02)00317-3

Takino, 1994, Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats, Yakugaku Zasshi, 114, 550, 10.1248/yakushi1947.114.8_550

Li, 2007, Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional Chinese medicine (TCM) in rats, Biol Pharm Bull, 30, 847, 10.1248/bpb.30.847

Gu, 2009, Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs, Food Chem Toxicol, 47, 2257, 10.1016/j.fct.2009.06.013

Xie, 2005, High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies, J Chromatogr B, 818, 167, 10.1016/j.jchromb.2004.12.028

Xie, 2005, Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharmacokinetic study in dogs, Eur J Drug Metab Pharmacokinet, 30, 63, 10.1007/BF03226409

Lai, 2009, Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro, Planta Med, 75, 797, 10.1055/s-0029-1185400

Joo, 2010, Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method, J Pharm Biomed Anal, 51, 278, 10.1016/j.jpba.2009.08.013

Kim, 2013, Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extract, J Ginseng Res, 37, 451, 10.5142/jgr.2013.37.451

Leung, 2010, Pharmacology of ginsenosides: a literature review, Chin Med, 5, 20, 10.1186/1749-8546-5-20

Qi, 2010, American ginseng: potential structure-function relationship in cancer chemoprevention, Biochem Pharmacol, 80, 947, 10.1016/j.bcp.2010.06.023

Liu, 2009, Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats, Drug Metab Dispos, 37, 2290, 10.1124/dmd.109.029819

Dai, 2016, Ginsenoside nanoparticle: a new green drug delivery system, J Mater Chem B, 4, 529, 10.1039/C5TB02305J

Li, 2011, Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes, Drug Metab Dispos, 39, 472, 10.1124/dmd.110.036723

Xiong, 2009, Active absorption of ginsenoside Rg1 in vitro and in vivo: the role of sodium-dependent glucose co-transporter 1, J Pharm Pharmacol, 61, 381, 10.1211/jpp/61.03.0014

Peng, 2016, Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg3 epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometry, J Pharmaceut Biomed, 121, 215, 10.1016/j.jpba.2016.01.020

Ren, 2008, Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats, J Pharm Biomed Anal, 48, 1476, 10.1016/j.jpba.2008.09.045

Li, 2006, High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues, Biomed Chromatogr, 20, 327, 10.1002/bmc.567

Feng, 2010, Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats, Arch Pharm Res, 33, 1975, 10.1007/s12272-010-1213-2

Hao, 2011, Mechanism-based pharmacokinetic-pharmacodynamic modeling of the estrogen-like effect of ginsenoside Rb1 on neural 5-HT in ovariectomized mice, Eur J Pharm Sci, 44, 117, 10.1016/j.ejps.2011.06.014

Toutain, 2004, Volumes of distribution, J Vet Pharmacol Ther, 27, 441, 10.1111/j.1365-2885.2004.00602.x

Gu, 2006, In vitro assessment of plasma protein binding of 20(R)-ginsenoside Rh2 by equilibrium dialysis and LC-MS analysis: a case of species differences, Biol Pharm Bull, 29, 951, 10.1248/bpb.29.951

Zeng, 2013, Systematic review of recent advances in pharmacokinetics of four classical Chinese medicines used for the treatment of cerebrovascular disease, Fitoterapia, 88, 50, 10.1016/j.fitote.2013.04.006

Tawab, 2003, Degradation of ginsenosides in humans after oral administration, Drug Metab Dispos, 31, 1065, 10.1124/dmd.31.8.1065

Yang, 2009, In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry, Anal Bioanal Chem, 395, 1441, 10.1007/s00216-009-3121-1

Yang, 2007, In vivo pharmacokinetic and metabolism studies of ginsenoside Rd, J Chromatogr B Analyt Technol Biomed Life Sci, 854, 77, 10.1016/j.jchromb.2007.04.014

Hao, 2010, Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship, Drug Metab Dispos, 38, 1731, 10.1124/dmd.110.033845

He, 2016, Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC-MS/MS: Rg1 excretion in rat bile, urine and feces, Acta Pharm Sin B, 6, 593, 10.1016/j.apsb.2016.05.001

Qian, 2005, In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3, J Chromatogr B Analyt Technol Biomed Life Sci, 816, 223, 10.1016/j.jchromb.2004.11.036

Toutain, 2004, Plasma clearance, J Vet Pharmacol Ther, 27, 415, 10.1111/j.1365-2885.2004.00605.x